A detailed history of Assenagon Asset Management S.A. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 185,777 shares of ACRS stock, worth $536,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185,777
Holding current value
$536,895
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$1.12 - $1.4 $208,070 - $260,087
185,777 New
185,777 $209,000
Q3 2023

Nov 06, 2023

BUY
$6.56 - $10.95 $330,007 - $550,850
50,306 Added 7.9%
687,135 $4.71 Million
Q2 2023

Jul 25, 2023

BUY
$7.89 - $10.64 $1.66 Million - $2.25 Million
211,001 Added 49.55%
636,829 $6.6 Million
Q1 2023

Apr 18, 2023

BUY
$7.07 - $17.95 $1.63 Million - $4.14 Million
230,905 Added 118.46%
425,828 $3.44 Million
Q3 2022

Oct 27, 2022

SELL
$13.07 - $18.22 $1.28 Million - $1.79 Million
-98,122 Reduced 33.48%
194,923 $3.07 Million
Q2 2022

Jul 27, 2022

SELL
$10.16 - $17.08 $2.18 Million - $3.66 Million
-214,390 Reduced 42.25%
293,045 $4.09 Million
Q1 2022

Apr 25, 2022

BUY
$9.74 - $17.92 $4.94 Million - $9.09 Million
507,435 New
507,435 $8.75 Million
Q4 2021

Feb 01, 2022

SELL
$12.27 - $18.49 $5.81 Million - $8.75 Million
-473,365 Closed
0 $0
Q3 2021

Oct 19, 2021

SELL
$13.38 - $18.8 $1.38 Million - $1.95 Million
-103,507 Reduced 17.94%
473,365 $8.52 Million
Q2 2021

Jul 15, 2021

BUY
$17.08 - $29.6 $9.5 Million - $16.5 Million
556,283 Added 2701.85%
576,872 $10.1 Million
Q1 2021

Apr 26, 2021

BUY
$5.86 - $27.73 $120,651 - $570,932
20,589 New
20,589 $519,000
Q3 2019

Oct 16, 2019

SELL
$0.79 - $2.47 $65,494 - $204,775
-82,905 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$2.13 - $7.06 $176,587 - $585,309
82,905 New
82,905 $182,000
Q1 2019

Apr 26, 2019

SELL
$5.63 - $7.84 $681,291 - $948,726
-121,011 Closed
0 $0
Q4 2018

Jan 23, 2019

BUY
$6.3 - $15.4 $762,369 - $1.86 Million
121,011 New
121,011 $894,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.